Psoriatic Arthritis Therapeutics Market Size, Share, And Growth Report 2032

• Chapter 1. Introduction
  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology
•  
• Chapter 2. Executive Summary
  • 2.1. Global psoriatic arthritis therapeutics market, 2016-2025 (USD Billion)
  • 2.2. Global psoriatic arthritis therapeutics market: Snapshot
•  
• Chapter 3. Infection Control Market - Industry Dynamics
  • 3.1. Introduction
  • 3.2. Market Drivers
    • 3.2.1. Global psoriatic arthritis therapeutics market drivers: impact analysis
    • 3.2.2. Increasing prevalence of psoriatic arthritis therapeutics
    • 3.2.3. The rising use of biologics
  • 3.3. Market Restraints
    • 3.3.1. Global psoriatic arthritis therapeutics market restraints: impact analysis
    • 3.3.2. The high cost of drugs
    • 3.3.3. The stringent regulatory approval process
  • 3.4. Opportunities
    • 3.4.1. Flourishing medical device and pharmaceutical industries in emerging economies
    • 3.4.2. Increasing investments by major market players
    • 3.4.3. Growing R&D activities
  • 3.5. Porter's Five Forces Analysis
  • 3.6. Market Attractiveness Analysis
    • 3.6.1. Market attractiveness analysis, by drug class
    • 3.6.2. Market attractiveness analysis, by disease type
    • 3.6.3. Market attractiveness analysis, by distribution channel
    • 3.6.4. Market attractiveness analysis, by region
•  
• Chapter 4. Global Infection Control Market - Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global psoriatic arthritis therapeutics market: company market share, 2018
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New therapy launch
    • 4.2.3. Agreements, partnerships, collaborations, and joint ventures
    • 4.2.4. Research and development and regional expansion
  • 4.3. Price trend analysis
•  
• Chapter 5. Global Infection Control Market - Drug Class Analysis
  • 5.1. Global psoriatic arthritis therapeutics market: drug class overview
    • 5.1.1. Global psoriatic arthritis therapeutics market revenue share, by drug class, 2018 and 2025
  • 5.2. Interleukin Inhibitors
    • 5.2.1. Global psoriatic arthritis therapeutics market for Interleukin Inhibitors, 2016-2025 (USD Billion)
  • 5.3. TNF Inhibitors
    • 5.3.1. Global psoriatic arthritis therapeutics market for TNF Inhibitors, 2016-2025 (USD Billion)
  • 5.4. PDE4 Inhibitors
    • 5.4.1. Global psoriatic arthritis therapeutics market for PDE4 Inhibitors, 2016-2025 (USD Billion)
  • 5.5. Others
    • 5.5.1. Global psoriatic arthritis therapeutics market for others, 2016-2025 (USD Billion)
•  
• Chapter 6. Global Infection Control Market - Disease Type Analysis
  • 6.1. Global psoriatic arthritis therapeutics market: disease type overview
    • 6.1.1. Global psoriatic arthritis therapeutics market revenue share, by disease type, 2018 and 2025
  • 6.2. Asymmetric Psoriatic Arthritis
    • 6.2.1. Global psoriatic arthritis therapeutics market for Asymmetric Psoriatic Arthritis, 2016-2025 (USD Billion)
  • 6.3. Symmetric Psoriatic Arthritis
    • 6.3.1. Global psoriatic arthritis therapeutics market for Symmetric Psoriatic Arthritis, 2016-2025 (USD Billion)
  • 6.4. Distal Interphalangeal Predominant (DIP) Psoriatic Arthritis
    • 6.4.1. Global psoriatic arthritis therapeutics market for Distal Interphalangeal Predominant (DIP) Psoriatic Arthritis, 2016-2025 (USD Billion)
  • 6.5. Spondylitis
    • 6.5.1. Global psoriatic arthritis therapeutics market for Spondylitis, 2016-2025 (USD Billion)
  • 6.6. Arthritis Mutilans
    • 6.6.1. Global psoriatic arthritis therapeutics market for Arthritis Mutilans, 2016-2025 (USD Billion)
•  
• Chapter 7. Global Infection Control Market - Distribution Channel Analysis
  • 7.1. Global psoriatic arthritis therapeutics market: distribution channel overview
    • 7.1.1. Global psoriatic arthritis therapeutics market revenue share, by distribution channel, 2018 and 2025
  • 7.2. Hospital Pharmacies
    • 7.2.1. Global psoriatic arthritis therapeutics market for Hospital Pharmacies, 2016-2025 (USD Billion)
  • 7.3. Online Pharmacies
    • 7.3.1. Global psoriatic arthritis therapeutics market for Online Pharmacies, 2016-2025 (USD Billion)
  • 7.4. Retail Pharmacies
    • 7.4.1. Global psoriatic arthritis therapeutics market for Retail Pharmacies, 2016-2025 (USD Billion)
•  
• Chapter 8. Global Infection Control Market - Regional Analysis
  • 8.1. Global psoriatic arthritis therapeutics market: regional overview
    • 8.1.1. Global psoriatic arthritis therapeutics market revenue share, by region, 2018 and 2025
  • 8.2. North America
    • 8.2.1. North America psoriatic arthritis therapeutics market revenue, by drug class, 2016-2025 (USD Billion)
    • 8.2.2. North America psoriatic arthritis therapeutics market revenue, by disease type, 2016-2025 (USD Billion)
    • 8.2.3. North America psoriatic arthritis therapeutics market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 8.2.4. The U.S.
      • 8.2.4.1. The U.S. psoriatic arthritis therapeutics market revenue, by drug class, 2016-2025 (USD Billion)
      • 8.2.4.2. The U.S. psoriatic arthritis therapeutics market revenue, by disease type, 2016-2025 (USD Billion)
      • 8.2.4.3. The U.S. psoriatic arthritis therapeutics market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 8.2.5. Rest of North America
      • 8.2.5.1. Rest of North America psoriatic arthritis therapeutics market revenue, by drug class, 2016-2025 (USD Billion)
      • 8.2.5.2. Rest of North America psoriatic arthritis therapeutics market revenue, by disease type, 2016-2025 (USD Billion)
      • 8.2.5.3. Rest of North America psoriatic arthritis therapeutics market revenue, by distribution channel, 2016-2025 (USD Billion)
  • 8.3. Europe
    • 8.3.1. Europe psoriatic arthritis therapeutics market revenue, by drug class, 2016-2025 (USD Billion)
    • 8.3.2. Europe psoriatic arthritis therapeutics market revenue, by disease type, 2016-2025 (USD Billion)
    • 8.3.3. Europe psoriatic arthritis therapeutics market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 8.3.4. UK
      • 8.3.4.1. UK psoriatic arthritis therapeutics market revenue, by drug class, 2016-2025 (USD Billion)
      • 8.3.4.2. UK psoriatic arthritis therapeutics market revenue, by disease type, 2016-2025 (USD Billion)
      • 8.3.4.3. UK psoriatic arthritis therapeutics market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 8.3.5. Germany
      • 8.3.5.1. Germany psoriatic arthritis therapeutics market revenue, by drug class, 2016-2025 (USD Billion)
      • 8.3.5.2. Germany psoriatic arthritis therapeutics market revenue, by disease type, 2016-2025 (USD Billion)
      • 8.3.5.3. Germany psoriatic arthritis therapeutics market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 8.3.6. France
      • 8.3.6.1. France psoriatic arthritis therapeutics market revenue, by drug class, 2016-2025 (USD Billion)
      • 8.3.6.2. France psoriatic arthritis therapeutics market revenue, by disease type, 2016-2025 (USD Billion)
      • 8.3.6.3. France psoriatic arthritis therapeutics market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 8.3.7. Rest of Europe
      • 8.3.7.1. Rest of Europe psoriatic arthritis therapeutics market revenue, by drug class, 2016-2025 (USD Billion)
      • 8.3.7.2. Rest of Europe psoriatic arthritis therapeutics market revenue, by disease type, 2016-2025 (USD Billion)
      • 8.3.7.3. Rest of Europe psoriatic arthritis therapeutics market revenue, by distribution channel, 2016-2025 (USD Billion)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific psoriatic arthritis therapeutics market revenue, by drug class, 2016-2025 (USD Billion)
    • 8.4.2. Asia Pacific psoriatic arthritis therapeutics market revenue, by disease type, 2016-2025 (USD Billion)
    • 8.4.3. Asia Pacific psoriatic arthritis therapeutics market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 8.4.4. China
      • 8.4.4.1. China psoriatic arthritis therapeutics market revenue, by drug class, 2016-2025 (USD Billion)
      • 8.4.4.2. China psoriatic arthritis therapeutics market revenue, by disease type, 2016-2025 (USD Billion)
      • 8.4.4.3. China psoriatic arthritis therapeutics market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 8.4.5. Japan
      • 8.4.5.1. Japan psoriatic arthritis therapeutics market revenue, by drug class, 2016-2025 (USD Billion)
      • 8.4.5.2. Japan psoriatic arthritis therapeutics market revenue, by disease type, 2016-2025 (USD Billion)
      • 8.4.5.3. Japan psoriatic arthritis therapeutics market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 8.4.6. India
      • 8.4.6.1. India psoriatic arthritis therapeutics market revenue, by drug class, 2016-2025 (USD Billion)
      • 8.4.6.2. India psoriatic arthritis therapeutics market revenue, by disease type, 2016-2025 (USD Billion)
      • 8.4.6.3. India psoriatic arthritis therapeutics market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 8.4.7. Rest of Asia Pacific
      • 8.4.7.1. Rest of Asia Pacific psoriatic arthritis therapeutics market revenue, by drug class, 2016-2025 (USD Billion)
      • 8.4.7.2. Rest of Asia Pacific psoriatic arthritis therapeutics market revenue, by disease type, 2016-2025 (USD Billion)
      • 8.4.7.3. Rest of Asia Pacific psoriatic arthritis therapeutics market revenue, by distribution channel, 2016-2025 (USD Billion)
  • 8.5. Latin America
    • 8.5.1. Latin America psoriatic arthritis therapeutics market revenue, by drug class, 2016-2025 (USD Billion)
    • 8.5.2. Latin America psoriatic arthritis therapeutics market revenue, by disease type, 2016-2025 (USD Billion)
    • 8.5.3. Latin America psoriatic arthritis therapeutics market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 8.5.4. Brazil
      • 8.5.4.1. Brazil psoriatic arthritis therapeutics market revenue, by drug class, 2016-2025 (USD Billion)
      • 8.5.4.2. Brazil psoriatic arthritis therapeutics market revenue, by disease type, 2016-2025 (USD Billion)
      • 8.5.4.3. Brazil psoriatic arthritis therapeutics market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 8.5.5. Rest of Latin America
      • 8.5.5.1. Rest of Latin America psoriatic arthritis therapeutics market revenue, by drug class, 2016-2025 (USD Billion)
      • 8.5.5.2. Rest of Latin America psoriatic arthritis therapeutics market revenue, by disease type, 2016-2025 (USD Billion)
      • 8.5.5.3. Rest of Latin America psoriatic arthritis therapeutics market revenue, by distribution channel, 2016-2025 (USD Billion)
  • 8.6. The Middle East and Africa
    • 8.6.1. The Middle East and Africa psoriatic arthritis therapeutics market revenue, by drug class, 2016-2025 (USD Billion)
    • 8.6.2. The Middle East and Africa psoriatic arthritis therapeutics market revenue, by disease type, 2016-2025 (USD Billion)
    • 8.6.3. The Middle East and Africa psoriatic arthritis therapeutics market revenue, by distribution channel, 2016-2025 (USD Billion)
•  
• Chapter 9. Company Profile
  • 9.1. AbbVie
    • 9.1.1. Overview
    • 9.1.2. Financials
    • 9.1.3. Product portfolio
    • 9.1.4. Business strategy
    • 9.1.5. Recent developments
  • 9.2. Amgen
    • 9.2.1. Overview
    • 9.2.2. Financials
    • 9.2.3. Product portfolio
    • 9.2.4. Business strategy
    • 9.2.5. Recent developments
  • 9.3. Janssen Biotech, Inc.
    • 9.3.1. Overview
    • 9.3.2. Financials
    • 9.3.3. Product portfolio
    • 9.3.4. Business strategy
    • 9.3.5. Recent developments
  • 9.4. UCB
    • 9.4.1. Overview
    • 9.4.2. Financials
    • 9.4.3. Product portfolio
    • 9.4.4. Business strategy
    • 9.4.5. Recent developments
  • 9.5. Celgene Corporation
    • 9.5.1. Overview
    • 9.5.2. Financials
    • 9.5.3. Product portfolio
    • 9.5.4. Business strategy
    • 9.5.5. Recent developments
  • 9.6. Pfizer
    • 9.6.1. Overview
    • 9.6.2. Financials
    • 9.6.3. Product portfolio
    • 9.6.4. Business strategy
    • 9.6.5. Recent developments
  • 9.7. Biogen
    • 9.7.1. Overview
    • 9.7.2. Financials
    • 9.7.3. Product portfolio
    • 9.7.4. Business strategy
    • 9.7.5. Recent developments
  • 9.8. Novartis AG
    • 9.8.1. Overview
    • 9.8.2. Financials
    • 9.8.3. Product portfolio
    • 9.8.4. Business strategy
    • 9.8.5. Recent developments
  • 9.9. Eli Lilly and Company
    • 9.9.1. Overview
    • 9.9.2. Financials
    • 9.9.3. Product portfolio
    • 9.9.4. Business strategy
    • 9.9.5. Recent developments
  • 9.10. Bristol-Myers Squibb
    • 9.10.1. Overview
    • 9.10.2. Financials
    • 9.10.3. Product portfolio
    • 9.10.4. Business strategy
    • 9.10.5. Recent developments

Table Of Figures

List of Figures

1. Market research process
2. Market methodology
3. Global psoriatic arthritis therapeutics market revenue, 2016–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Psoriatic Arthritis Therapeutics market attractiveness analysis, by drug class
6. Psoriatic Arthritis Therapeutics market attractiveness analysis, by disease type
7. Psoriatic Arthritis Therapeutics market attractiveness analysis, by distribution channel
8. Psoriatic Arthritis Therapeutics market attractiveness analysis, by region
9. Company market share analysis, 2018
10. Global psoriatic arthritis therapeutics market revenue share by drug class, 2018 and 2025
11. Global psoriatic arthritis therapeutics market for Interleukin Inhibitors, 2016–2025 (USD Billion)
12. Global psoriatic arthritis therapeutics market for TNF Inhibitors, 2016–2025 (USD Billion)
13. Global psoriatic arthritis therapeutics market for PDE4 Inhibitors, 2016–2025 (USD Billion)
14. Global psoriatic arthritis therapeutics market for Others, 2016–2025 (USD Billion)
15. Global psoriatic arthritis therapeutics market revenue share by disease type, 2018 and 2025
16. Global psoriatic arthritis therapeutics market for Asymmetric Psoriatic Arthritis, 2016–2025 (USD Billion)
17. Global psoriatic arthritis therapeutics market for Symmetric Psoriatic Arthritis, 2016–2025 (USD Billion)
18. Global psoriatic arthritis therapeutics market for Distal Interphalangeal Predominant (DIP) Psoriatic Arthritis, 2016–2025 (USD Billion)
19. Global psoriatic arthritis therapeutics market for Spondylitis, 2016–2025 (USD Billion)
20. Global psoriatic arthritis therapeutics market for Arthritis Mutilans, 2016–2025 (USD Billion)
21. Global psoriatic arthritis therapeutics market revenue share by distribution channel, 2018 and 2025
22. Global psoriatic arthritis therapeutics market for Hospital Pharmacies, 2016–2025 (USD Billion)
23. Global psoriatic arthritis therapeutics market for Online Pharmacies, 2016–2025 (USD Billion)
24. Global psoriatic arthritis therapeutics market for Retail Pharmacies, 2016–2025 (USD Billion)
25. Global psoriatic arthritis therapeutics market revenue share by region, 2018 and 2025
26. North America psoriatic arthritis therapeutics market, 2016–2025 (USD Billion)
27. Europe psoriatic arthritis therapeutics market, 2016–2025 (USD Billion)
28. Asia Pacific psoriatic arthritis therapeutics market, 2016–2025 (USD Billion)
29. Latin America psoriatic arthritis therapeutics market, 2016–2025 (USD Billion)
30. The Middle East and Africa psoriatic arthritis therapeutics market, 2016–2025 (USD Billion)

Table Of Tables

List of Tables

1. Psoriatic arthritis therapeutics market: Market Snapshot                                                                                                             
2. Drivers of the global psoriatic arthritis therapeutics market: impact analysis 
3. Restraints of the global psoriatic arthritis therapeutics market: impact analysis
4. North America psoriatic arthritis therapeutics market revenue, by drug class, 2016–2025 (USD Billion)
5. North America psoriatic arthritis therapeutics market revenue, by disease type, 2016–2025 (USD Billion)
6. North America psoriatic arthritis therapeutics market revenue, by distribution channel, 2016–2025 (USD Billion)
7. The U.S. psoriatic arthritis therapeutics market revenue, by drug class, 2016–2025 (USD Billion)
8. The U.S. psoriatic arthritis therapeutics market revenue, by disease type, 2016–2025 (USD Billion)
9. The U.S. psoriatic arthritis therapeutics market revenue, by distribution channel, 2016–2025 (USD Billion)
10. Rest of North America psoriatic arthritis therapeutics market revenue, by drug class, 2016–2025 (USD Billion)
11. Rest of North America psoriatic arthritis therapeutics market revenue, by disease type, 2016–2025 (USD Billion)
12. Rest of North America psoriatic arthritis therapeutics market revenue, by distribution channel, 2016–2025 (USD Billion)
13. Europe psoriatic arthritis therapeutics market revenue, by drug class, 2016–2025 (USD Billion)
14. Europe psoriatic arthritis therapeutics market revenue, by disease type, 2016–2025 (USD Billion)
15. Europe psoriatic arthritis therapeutics market revenue, by distribution channel, 2016–2025 (USD Billion)
16. UK psoriatic arthritis therapeutics market revenue, by drug class, 2016–2025 (USD Billion)
17. UK psoriatic arthritis therapeutics market revenue, by disease type, 2016–2025 (USD Billion)
18. UK psoriatic arthritis therapeutics market revenue, by distribution channel, 2016–2025 (USD Billion)
19. Germany psoriatic arthritis therapeutics market revenue, by drug class, 2016–2025 (USD Billion)
20. Germany psoriatic arthritis therapeutics market revenue, by disease type, 2016–2025 (USD Billion)
21. Germany psoriatic arthritis therapeutics market revenue, by distribution channel, 2016–2025 (USD Billion)
22. France psoriatic arthritis therapeutics market revenue, by drug class, 2016–2025 (USD Billion)
23. France psoriatic arthritis therapeutics market revenue, by disease type, 2016–2025 (USD Billion)
24. France psoriatic arthritis therapeutics market revenue, by distribution channel, 2016–2025 (USD Billion)
25. Rest of Europe psoriatic arthritis therapeutics market revenue, by drug class, 2016–2025 (USD Billion)
26. Rest of Europe psoriatic arthritis therapeutics market revenue, by disease type, 2016–2025 (USD Billion)
27. Rest of Europe psoriatic arthritis therapeutics market revenue, by distribution channel, 2016–2025 (USD Billion)
28. Asia Pacific psoriatic arthritis therapeutics market revenue, by drug class, 2016–2025 (USD Billion)
29. Asia Pacific psoriatic arthritis therapeutics market revenue, by disease type, 2016–2025 (USD Billion)
30. Asia Pacific psoriatic arthritis therapeutics market revenue, by distribution channel, 2016–2025 (USD Billion)
31. China psoriatic arthritis therapeutics market revenue, by drug class, 2016–2025 (USD Billion)
32. China psoriatic arthritis therapeutics market revenue, by disease type, 2016–2025 (USD Billion)
33. China psoriatic arthritis therapeutics market revenue, by distribution channel, 2016–2025 (USD Billion)
34. Japan psoriatic arthritis therapeutics market revenue, by drug class, 2016–2025 (USD Billion)
35. Japan psoriatic arthritis therapeutics market revenue, by disease type, 2016–2025 (USD Billion)
36. Japan psoriatic arthritis therapeutics market revenue, by distribution channel, 2016–2025 (USD Billion)
37. India psoriatic arthritis therapeutics market revenue, by drug class, 2016–2025 (USD Billion)
38. India psoriatic arthritis therapeutics market revenue, by disease type, 2016–2025 (USD Billion)
39. India psoriatic arthritis therapeutics market revenue, by distribution channel, 2016–2025 (USD Billion)
40. Rest of Asia Pacific psoriatic arthritis therapeutics market revenue, by drug class, 2016–2025 (USD Billion)
41. Rest of Asia Pacific psoriatic arthritis therapeutics market revenue, by disease type, 2016–2025 (USD Billion)
42. Rest of Asia Pacific psoriatic arthritis therapeutics market revenue, by distribution channel, 2016–2025 (USD Billion)
43. Latin America psoriatic arthritis therapeutics market revenue, by drug class, 2016–2025 (USD Billion)
44. Latin America psoriatic arthritis therapeutics market revenue, by disease type, 2016–2025 (USD Billion)
45. Latin America psoriatic arthritis therapeutics market revenue, by distribution channel, 2016–2025 (USD Billion)
46. Brazil psoriatic arthritis therapeutics market revenue, by drug class, 2016–2025 (USD Billion)
47. Brazil psoriatic arthritis therapeutics market revenue, by disease type, 2016–2025 (USD Billion)
48. Brazil psoriatic arthritis therapeutics market revenue, by distribution channel, 2016–2025 (USD Billion)
49. Rest of Latin America psoriatic arthritis therapeutics market revenue, by drug class, 2016–2025 (USD Billion)
50. Rest of Latin America psoriatic arthritis therapeutics market revenue, by disease type, 2016–2025 (USD Billion)
51. Rest of Latin America psoriatic arthritis therapeutics market revenue, by distribution channel, 2016–2025 (USD Billion)
52. The Middle East and Africa psoriatic arthritis therapeutics market revenue, by drug class, 2016–2025 (USD Billion)
53. The Middle East and Africa psoriatic arthritis therapeutics market revenue, by disease type, 2016–2025 (USD Billion)
54. The Middle East and Africa psoriatic arthritis therapeutics market revenue, by distribution channel, 2016–2025 (USD Billion)